Grigoriu et al. reported considerably elevated levels of endocan (typical range in serum: 300–1200 pg / mL) in lung tumor tissue when compared to healthy lung tissue, and suggested that endocan may correlate with adverse prognosis in lung cancer patients [16]. This evidence concerns the gene ESM1 and lung carcinoma.